{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:38:51Z","timestamp":1788928731346,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Die Demenz mit Lewy-K\u00f6rpern (DLK) ist nach der Alzheimer-Krankheit die zweith\u00e4ufigste neurodegenerative Demenzerkrankung. Patienten mit DLK haben oft eine schlechte Prognose, mit schlechteren Ergebnissen als Patienten mit der Alzheimer-Krankheit in Bezug auf wichtige Parameter wie Lebensqualit\u00e4t, Belastung der Pflegepersonen, gesundheitsbezogene Kosten, Einweisungsh\u00e4ufigkeit in Krankenh\u00e4user und Pflegeheime, k\u00fcrzerer Zeitraum bis zur schweren Demenz und eine geringere \u00dcberlebensrate. Die DLK wird h\u00e4ufig fehldiagnostiziert und ist oft unterbehandelt. Daher ist es von entscheidender Bedeutung, die DLK so fr\u00fch wie m\u00f6glich zu diagnostizieren, um eine optimale Versorgung und Behandlung zu gew\u00e4hrleisten.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel der Arbeit<\/jats:title>\n                <jats:p>In diesem \u00dcbersichtsartikel sollen die wichtigsten neuen Erkenntnisse zu diagnostischen Instrumenten, der Epidemiologie und Genetik der Demenz mit Lewy-K\u00f6rpern zusammengetragen werden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Es existieren pr\u00e4zise klinischen Diagnosekriterien f\u00fcr die DLK, die eine \u00e4tiologische Zuordnung zulassen. Bildgebende Verfahren kommen standardm\u00e4\u00dfig bei der DLK zum Einsatz, insbesondere auch, um nicht neurodegenerative Ursachen auszuschlie\u00dfen. Insbesondere nuklearmedizinische Verfahren besitzen eine hohe diagnostische Aussagekraft.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Die Diagnose beruht in erster Linie auf der klinischen Symptomatik, obwohl die Entwicklung von In-vivo-Neurobildgebung und Biomarkern den Umfang der klinischen Diagnose sowie die Erforschung dieser verheerenden Krankheit ver\u00e4ndert.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00115-023-01576-3","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T18:02:09Z","timestamp":1702490529000},"page":"353-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Demenz mit Lewy-K\u00f6rpern: alte und neue Erkenntnisse \u2013 Teil\u00a01: Klinik und Diagnostik","Dementia with Lewy bodies: old and new knowledge \u2013 Part 1: clinical aspects and diagnostics"],"prefix":"10.1007","volume":"95","author":[{"given":"Richard","family":"Dodel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Duning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Storch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"issue":"1","key":"1576_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith\u00a0IG, Boeve\u00a0BF, Dickson\u00a0DW et\u00a0al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"key":"1576_CR2","first-page":"157","volume-title":"Parkinson-Syndrome und andere Bewegungsst\u00f6rungen","author":"R Dodel","year":"2020","unstructured":"Dodel\u00a0R, Deuschl\u00a0G (2020) Demenz mit Lewy-K\u00f6rpern. In: Oertel\u00a0W, Deuschl\u00a0G, Poewe W (Hrsg) Parkinson-Syndrome und andere Bewegungsst\u00f6rungen. Thieme, Stuttgart, S 157\u2013180"},{"issue":"4","key":"1576_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"R Skogseth","year":"2017","unstructured":"Skogseth\u00a0R, Hortobagyi\u00a0T, Soennesyn\u00a0H et\u00a0al (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus Neuropathology. J\u00a0Alzheimers Dis 59(4):1139\u20131152","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1576_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo\u00a0JB, Abdelnour\u00a0C, Weil\u00a0RS et al (2023) Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design. Alzheimers Dement 19(1):318\u2013332","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1576_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3233\/JAD-170914","volume":"63","author":"J Roudil","year":"2018","unstructured":"Roudil\u00a0J, Deramecourt\u00a0V, Dufournet\u00a0B et al (2018) Influence of Lewy pathology on alzheimer\u2019s disease phenotype: a\u00a0retrospective Clinico-pathological study. J\u00a0Alzheimers Dis 63(4):1317\u20131323","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1576_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.dadm.2015.05.004","volume":"1","author":"JE Galvin","year":"2015","unstructured":"Galvin\u00a0JE (2015) Improving the clinical detection of Lewy body dementia with the Lewy body composite risk. Score Alzheimers Dement (Amst) 1(3):316\u2013324","journal-title":"Score Alzheimers Dement (Amst)"},{"issue":"12","key":"1576_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma\u00a0RB, Berg\u00a0D, Stern\u00a0M et\u00a0al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"17","key":"1576_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith\u00a0IG, Ferman\u00a0TJ, Thomas\u00a0AJ et\u00a0al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94(17):743\u2013755","journal-title":"Neurology"},{"issue":"11","key":"1576_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/mds.26721","volume":"31","author":"BF Boeve","year":"2016","unstructured":"Boeve\u00a0BF, Dickson\u00a0DW, Duda\u00a0JE et\u00a0al (2016) Arguing against the proposed definition changes of PD. Mov Disord 31(11):1619\u20131622","journal-title":"Mov Disord"},{"issue":"3","key":"1576_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma\u00a0RB, Iranzo\u00a0A, Hu\u00a0M et\u00a0al (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a\u00a0multicentre study. Brain 142(3):744\u2013759","journal-title":"Brain"},{"issue":"5","key":"1576_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ana.25239","volume":"83","author":"D Genier Marchand","year":"2018","unstructured":"Genier Marchand\u00a0D, Postuma\u00a0RB, Escudier\u00a0F et\u00a0al (2018) How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder. Ann Neurol 83(5):1016\u20131026","journal-title":"Ann Neurol"},{"issue":"11","key":"1576_CR12","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1093\/brain\/awz235","volume":"142","author":"S O\u2019Dowd","year":"2019","unstructured":"O\u2019Dowd\u00a0S, Schumacher\u00a0J, Burn\u00a0DJ et\u00a0al (2019) Fluctuating cognition in the Lewy body dementias. Brain 142(11):3338\u20133350","journal-title":"Brain"},{"issue":"9","key":"1576_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jagp.2013.01.072","volume":"22","author":"DR Lee","year":"2014","unstructured":"Lee\u00a0DR, McKeith\u00a0I, Mosimann\u00a0U et\u00a0al (2014) The dementia cognitive fluctuation scale, a\u00a0new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. Am J Geriatr Psychiatry 22(9):926\u2013935","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"1576_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/gps.4948","volume":"33","author":"AJ Thomas","year":"2018","unstructured":"Thomas\u00a0AJ, Taylor\u00a0JP, McKeith\u00a0I et\u00a0al (2018) Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. Int J Geriatr Psychiatry 33(10):1293\u20131304","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"1576_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000165917","volume":"26","author":"D Aarsland","year":"2008","unstructured":"Aarsland\u00a0D, Rongve\u00a0A, Nore\u00a0SP et\u00a0al (2008) Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord 26(5):445\u2013452","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1576_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-6-2","volume":"6","author":"J Zaccai","year":"2006","unstructured":"Zaccai\u00a0J, Ince\u00a0P, Brayne\u00a0C (2006) Population-based neuropathological studies of dementia: design, methods and areas of investigation\u2014a systematic review. BMC Neurol 6:2","journal-title":"BMC Neurol"},{"issue":"3","key":"1576_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1750-3639.2008.00169.x","volume":"18","author":"K Fujimi","year":"2008","unstructured":"Fujimi\u00a0K, Sasaki\u00a0K, Noda\u00a0K et\u00a0al (2008) Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol 18(3):317\u2013325","journal-title":"Brain Pathol"},{"key":"1576_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2002.tb04794.x","volume":"977","author":"L White","year":"2002","unstructured":"White\u00a0L, Petrovitch\u00a0H, Hardman\u00a0J et al (2002) Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977:9\u201323","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"1576_CR19","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan\u00a0DB, Fiest\u00a0KM, Roberts\u00a0JI et\u00a0al (2016) The prevalence and incidence of dementia with Lewy bodies: a\u00a0systematic review. Can J Neurol Sci 43(Suppl 1):S83\u2013S95","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"1576_CR20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1212\/01.wnl.0000247041.63081.98","volume":"67","author":"MM Williams","year":"2006","unstructured":"Williams\u00a0MM, Xiong\u00a0C, Morris\u00a0JC et al (2006) Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 67(11):1935\u20131941","journal-title":"Neurology"},{"key":"1576_CR21","doi-asserted-by":"publisher","first-page":"7631951","DOI":"10.1155\/2018\/7631951","volume":"2018","author":"SK Yang","year":"2018","unstructured":"Yang\u00a0SK, Chen\u00a0W, Su\u00a0CH et al (2018) Incidence and comorbidity of dementia with Lewy bodies: a\u00a0population-based cohort study. Behav Neurol 2018:7631951","journal-title":"Behav Neurol"},{"issue":"10","key":"1576_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11910-018-0874-y","volume":"18","author":"T Orme","year":"2018","unstructured":"Orme\u00a0T, Guerreiro\u00a0R, Bras\u00a0J (2018) The genetics of dementia with Lewy bodies: current understanding and future directions. Curr Neurol Neurosci Rep 18(10):67","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"1576_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/gps.5260","volume":"35","author":"H Sanghvi","year":"2020","unstructured":"Sanghvi\u00a0H, Singh\u00a0R, Morrin\u00a0H et al (2020) Systematic review of genetic association studies in people with Lewy body dementia. Int J Geriatr Psychiatry 35(5):436\u2013448","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"1576_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11910-017-0737-y","volume":"17","author":"K Rosborough","year":"2017","unstructured":"Rosborough\u00a0K, Patel\u00a0N, Kalia\u00a0LV (2017) alpha-Synuclein and Parkinsonism: updates and future perspectives. Curr Neurol Neurosci Rep 17(4):31","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"1576_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls\u00a0MA, Duran\u00a0R, Lopez\u00a0G et\u00a0al (2013) A\u00a0multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 70(6):727\u2013735","journal-title":"JAMA Neurol"},{"issue":"1","key":"1576_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro\u00a0R, Ross\u00a0OA, Kun-Rodrigues\u00a0C et al (2018) Investigating the genetic architecture of dementia with Lewy bodies: a\u00a0two-stage genome-wide association study. Lancet Neurol 17(1):64\u201374","journal-title":"Lancet Neurol"},{"issue":"1","key":"1576_CR27","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1038\/s41598-019-43458-2","volume":"9","author":"A Rongve","year":"2019","unstructured":"Rongve\u00a0A, Witoelar\u00a0A, Ruiz\u00a0A et\u00a0al (2019) GBA and APOE epsilon4 associate with sporadic dementia with Lewy bodies in European genome wide association study. Sci Rep 9(1):7013","journal-title":"Sci Rep"},{"issue":"3","key":"1576_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia\u00a0R, Sabir\u00a0MS, Bandres-Ciga\u00a0S et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53(3):294\u2013303","journal-title":"Nat Genet"},{"issue":"4","key":"1576_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ejhg.2013.182","volume":"22","author":"E Malini","year":"2014","unstructured":"Malini\u00a0E, Grossi\u00a0S, Deganuto\u00a0M et\u00a0al (2014) Functional analysis of 11 novel GBA alleles. Eur J Hum Genet 22(4):511\u2013516","journal-title":"Eur J Hum Genet"},{"key":"1576_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.07.009","volume":"43","author":"LJM Vergouw","year":"2017","unstructured":"Vergouw\u00a0LJM, van Steenoven\u00a0I, van de Berg\u00a0WDJ et\u00a0al (2017) An update on the genetics of dementia with Lewy bodies. Park Relat Disord 43:1\u20138","journal-title":"Park Relat Disord"},{"issue":"3","key":"1576_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archneur.63.3.370","volume":"63","author":"JB Leverenz","year":"2006","unstructured":"Leverenz\u00a0JB, Fishel\u00a0MA, Peskind\u00a0ER et al (2006) Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 63(3):370\u2013376","journal-title":"Arch Neurol"},{"issue":"1","key":"1576_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-180687","volume":"67","author":"G Rizzo","year":"2019","unstructured":"Rizzo G, De Blasi R, Capozzo R et al (2019) Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies. J Alzheimers Dis 67(1):61-65","journal-title":"J Alzheimers Dis"},{"key":"1576_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2020.12.009","volume":"99","author":"T Miyagawa","year":"2021","unstructured":"Miyagawa\u00a0T, Przybelski\u00a0SA, Maltais\u00a0D et al (2021) The value of multimodal imaging with (123)I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer\u2019s disease dementia. Neurobiol Aging 99:11\u201318","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1576_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.parkreldis.2011.09.015","volume":"18","author":"ND Papathanasiou","year":"2012","unstructured":"Papathanasiou ND, Boutsiadis A, Dickson J et al (2012) Diagnostic accuracy of (1)(2)(3)I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord 18(3):225-9.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1576_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/acn3.521","volume":"5","author":"Y Jung","year":"2018","unstructured":"Jung\u00a0Y, Jordan\u00a0LG 3rd, Lowe\u00a0VJ et al (2018) Clinicopathological and (123)I-FP-CIT SPECT correlations in patients with dementia. Ann Clin Transl Neurol 5(3):376\u2013381","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1576_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","volume":"88","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Attems J, Colloby SJ, et al (2017) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 88(3):276-83.","journal-title":"Neurology"},{"issue":"11","key":"1576_CR37","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","volume":"78","author":"Z Walker","year":"2007","unstructured":"Walker Z, Jaros E, Walker RW,  et al (2007) Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 78(11):1176-81.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1576_CR38","first-page":"2798","volume":"9","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT et al (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain 135(Pt 9):2798-808.","journal-title":"Pt"},{"issue":"6","key":"1576_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","volume":"43","author":"JJ van der Zande","year":"2016","unstructured":"van der Zande\u00a0JJ, Booij\u00a0J, Scheltens\u00a0P et al (2016) (123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 43(6):1060\u20131066","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1576_CR40","first-page":"215","volume":"82","author":"L Frings","year":"2021","unstructured":"Frings L, Henninger F, Treppner M et al (2021) DAT SPECT Predicts Survival in Patients Assessed for Differential Diagnosis of Dementia. J Alzheimers Dis 82(1):215-20.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"1576_CR41","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima\u00a0S, Frey\u00a0KA, Koeppe\u00a0RA et al (1995) A\u00a0diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J\u00a0Nucl Med 36(7):1238\u20131248","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"1576_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia\u00a0G, Cason\u00a0E (2012) Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a\u00a0systematic review and a\u00a0meta-analysis. J\u00a0Neuroimaging 22(2):111\u2013117","journal-title":"J Neuroimaging"},{"issue":"4","key":"1576_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","volume":"89","author":"G Rizzo","year":"2018","unstructured":"Rizzo G, Arcuti S, Copetti M et al (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89(4):358-366","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1576_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/jnnp-2017-317398","volume":"89","author":"J Komatsu","year":"2018","unstructured":"Komatsu J, Samuraki M, Nakajima K et al (2018) (123)I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry 89(11):1167-73.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1576_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jnnp-2015-310686","volume":"86","author":"M Takahashi","year":"2015","unstructured":"Takahashi\u00a0M, Ikemura\u00a0M, Oka\u00a0T et\u00a0al (2015) Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J\u00a0Neurol Neurosurg Psychiatry 86(9):939\u2013944","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1576_CR46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima\u00a0S, Foster\u00a0NL, Sima\u00a0AA et\u00a0al (2001) Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50(3):358\u2013365","journal-title":"Ann Neurol"},{"issue":"9","key":"1576_CR47","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00259-018-4035-y","volume":"45","author":"PJ Nestor","year":"2018","unstructured":"Nestor\u00a0PJ, Altomare\u00a0D, Festari\u00a0C et al (2018) Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. Eur J Nucl Med Mol Imaging 45(9):1509\u20131525","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"1576_CR48","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2967\/jnumed.115.159822","volume":"56","author":"S Hellwig","year":"2015","unstructured":"Hellwig S, Frings L, Amtage F et al (2015) 18F-FDG PET is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism. J Nucl Med 56(10):1541-6.","journal-title":"J Nucl Med"},{"issue":"12","key":"1576_CR49","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2967\/jnumed.114.143347","volume":"55","author":"JT O\u2019Brien","year":"2014","unstructured":"O\u2019Brien JT, Firbank MJ, Davison C (2014) 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. J Nucl Med 55(12):1959-65.","journal-title":"J Nucl Med"},{"issue":"1","key":"1576_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JAD-150675","volume":"50","author":"A Mishima","year":"2016","unstructured":"Mishima\u00a0A, Nihashi\u00a0T, Ando\u00a0Y et al (2016) Biomarkers differentiating dementia with Lewy bodies from other dementias: a\u00a0meta-analysis. J\u00a0Alzheimers Dis 50(1):161\u2013174","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1576_CR51","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","volume":"50","author":"SM Lim","year":"2009","unstructured":"Lim SM, Katsifis A, Villemagne VL et al (2009) The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50(10):1638-45","journal-title":"J Nucl Med"},{"issue":"4","key":"1576_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/psyg.12227","volume":"17","author":"S Kobayashi","year":"2017","unstructured":"Kobayashi\u00a0S, Makino\u00a0K, Hatakeyama\u00a0S et al (2017) The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and (123) I\u2011metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Psychogeriatrics 17(4):247\u2013255","journal-title":"Psychogeriatrics"},{"issue":"2","key":"1576_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","volume":"24","author":"G Treglia","year":"2014","unstructured":"Treglia G, Cason E, Cortelli P et al (2014) Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging 24(2):149-54.","journal-title":"J Neuroimaging"},{"issue":"5","key":"1576_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/ggi.12794","volume":"17","author":"S Shimizu","year":"2017","unstructured":"Shimizu\u00a0S, Kanetaka\u00a0H, Hirao\u00a0K et\u00a0al (2017) Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer\u2019s disease? Geriatr Gerontol Int 17(5):819\u2013824","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1576_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","volume":"43","author":"S Shimizu","year":"2016","unstructured":"Shimizu S, Hirao K, Kanetaka H et al (2016) Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 43(1):184-92","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1576_CR56","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/WCO.0000000000000106","volume":"27","author":"PT Meyer","year":"2014","unstructured":"Meyer PT, Hellwig S (2014) Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis. Curr Opin Neurol 27(4):390-7.","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"1576_CR57","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer\u00a0PT, Frings\u00a0L, Rucker\u00a0G et al (2017) (18)F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J\u00a0Nucl Med 58(12):1888\u20131898","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"1576_CR58","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Chetelat","year":"2020","unstructured":"Chetelat G, Arbizu J, Barthel H et al (2020) Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19(11):951-62.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1576_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","volume":"23","author":"P Donaghy","year":"2015","unstructured":"Donaghy\u00a0P, Thomas\u00a0AJ, O\u2019Brien\u00a0JT (2015) Amyloid PET imaging in Lewy body disorders. Am J Geriatr Psychiatry 23(1):23\u201337","journal-title":"Am J Geriatr Psychiatry"},{"issue":"24","key":"1576_CR60","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","volume":"95","author":"D Ferreira","year":"2020","unstructured":"Ferreira\u00a0D, Przybelski\u00a0SA, Lesnick\u00a0TG et al (2020) beta-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies. Neurology 95(24):e3257\u2013e3268","journal-title":"Neurology"},{"issue":"12","key":"1576_CR61","doi-asserted-by":"publisher","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","volume":"2","author":"Z Nedelska","year":"2019","unstructured":"Nedelska\u00a0Z, Schwarz\u00a0CG, Lesnick\u00a0TG et al (2019) Association of longitudinal beta-amyloid accumulation determined by positron emission Tomography with clinical and cognitive decline in adults with probable Lewy body dementia. JAMA Netw Open 2(12):e1916439","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1576_CR62","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","volume":"93","author":"J Shirvan","year":"2019","unstructured":"Shirvan\u00a0J, Clement\u00a0N, Ye\u00a0R et\u00a0al (2019) Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology 93(5):e476\u2013e484","journal-title":"Neurology"},{"issue":"9","key":"1576_CR63","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","volume":"33","author":"K Kantarci","year":"2012","unstructured":"Kantarci\u00a0K, Lowe\u00a0VJ, Boeve\u00a0BF et\u00a0al (2012) Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging 33(9):2091\u20132105","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1576_CR64","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1212\/WNL.0000000000008818","volume":"94","author":"K Kantarci","year":"2020","unstructured":"Kantarci\u00a0K, Lowe\u00a0VJ, Chen\u00a0Q et al (2020) beta-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology 94(3):e282\u2013e291","journal-title":"Neurology"},{"issue":"11","key":"1576_CR65","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts\u00a0SN, Locascio\u00a0JJ, Makaretz\u00a0SJ et\u00a0al (2016) Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol 73(11):1334\u20131341","journal-title":"JAMA Neurol"},{"issue":"1","key":"1576_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci\u00a0K, Lowe\u00a0VJ, Boeve\u00a0BF et al (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81(1):58\u201367","journal-title":"Ann Neurol"},{"issue":"11","key":"1576_CR67","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele\u00a0R, Rabinovici\u00a0GD, Smith\u00a0R et\u00a0al (2018) Discriminative accuracy of [18F]flortaucipir positron emission Tomography for alzheimer disease vs other neurodegenerative disorders. JAMA 320(11):1151\u20131162","journal-title":"JAMA"},{"issue":"3","key":"1576_CR68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27603","volume":"34","author":"Z Nedelska","year":"2019","unstructured":"Nedelska\u00a0Z, Josephs\u00a0KA, Graff-Radford\u00a0J et al (2019) (18) F\u2011AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy. Mov Disord 34(3):344\u2013352","journal-title":"Mov Disord"},{"issue":"9","key":"1576_CR69","doi-asserted-by":"publisher","first-page":"e1358","DOI":"10.1212\/WNL.0000000000011521","volume":"96","author":"G Blazhenets","year":"2021","unstructured":"Blazhenets\u00a0G, Frings\u00a0L, Ma\u00a0Y et al (2021) Validation of the Alzheimer disease dementia conversion-related pattern as an ATN Biomarker of neurodegeneration. Neurology 96(9):e1358\u2013e1368","journal-title":"Neurology"},{"issue":"7","key":"1576_CR70","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","volume":"82","author":"F Holtbernd","year":"2014","unstructured":"Holtbernd\u00a0F, Gagnon\u00a0JF, Postuma\u00a0RB et\u00a0al (2014) Abnormal metabolic network activity in REM sleep behavior disorder. Neurology 82(7):620\u2013627","journal-title":"Neurology"},{"issue":"12","key":"1576_CR71","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","volume":"90","author":"A Pilotto","year":"2018","unstructured":"Pilotto\u00a0A, Premi\u00a0E, Caminiti\u00a0PS et al (2018) Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology 90(12):e1029\u2013e1037","journal-title":"Neurology"},{"issue":"23","key":"1576_CR72","doi-asserted-by":"publisher","first-page":"e2801","DOI":"10.1212\/WNL.0000000000012060","volume":"96","author":"G Roberts","year":"2021","unstructured":"Roberts\u00a0G, Durcan\u00a0R, Donaghy\u00a0PC et\u00a0al (2021) Accuracy of cardiac innervation Scintigraphy for mild cognitive impairment with Lewy bodies. Neurology 96(23):e2801\u2013e2811","journal-title":"Neurology"},{"issue":"5","key":"1576_CR73","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s12350-019-01977-5","volume":"28","author":"G Roberts","year":"2021","unstructured":"Roberts\u00a0G, Lloyd\u00a0JJ, Jefferson\u00a0E et al (2021) Uniformity of cardiac (123)I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia. J\u00a0Nucl Cardiol 28(5):2151\u20132163","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"1576_CR74","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/jon.12643","volume":"29","author":"Y Chiba","year":"2019","unstructured":"Chiba\u00a0Y, Fujishiro\u00a0H, Iseki\u00a0E et al (2019) The Cingulate island sign on FDG-PET vs. IMP-SPECT to assess mild cognitive impairment in Alzheimer\u2019s disease vs. Dementia with Lewy bodies. J\u00a0Neuroimaging 29(6):712\u2013720","journal-title":"J\u00a0Neuroimaging"},{"key":"1576_CR75","doi-asserted-by":"crossref","unstructured":"Chen Q, Lowe VJ, Boeve BF et al (2021) beta-Amyloid PET and (123)I-FP-CIT SPECT in mild cognitive impairment at risk for Lewy body dementia. Neurology 96(8):e1180-9","DOI":"10.1212\/WNL.0000000000011454"},{"issue":"3","key":"1576_CR76","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.dadm.2015.05.004","volume":"1","author":"JE Galvin","year":"2015","unstructured":"Galvin JE. Improving the clinical detection of Lewy body dementia with the Lewy Body Composite Risk Score (2015) Alzheimers Dement (Amst) 1(3):316-324","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"1576_CR77","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR, Jr., Bennett DA, Blennow K et al (2018) Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535-62.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1576_CR78","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, Rucker G, et al (2017) (18)F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment. J Nucl Med 58(12):1888-98.","journal-title":"J Nucl Med"},{"issue":"11","key":"1576_CR79","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Chetelat","year":"2020","unstructured":"Chetelat G, Arbizu J, Barthel H  et al (2020) Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19(11):951-62.","journal-title":"Lancet Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-023-01576-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01576-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T12:02:10Z","timestamp":1712923330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-023-01576-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1007\/s00115-023-01576-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"26 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Dodel, D.\u00a0Berg, T.\u00a0Duning, E.\u00a0Kalbe, P.T.\u00a0Meyer, A.\u00a0Ramirez, A.\u00a0Storch, D.\u00a0Aarsland und F.\u00a0Jessen geben an, dass kein Interessenkonflikt bez\u00fcglich des Inhaltes des Artikels besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}